Literature DB >> 22063389

Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.

Daniel C L Linhares1, Jean Paul Cano, Thomas Wetzell, Joel Nerem, Montserrat Torremorell, Scott A Dee.   

Abstract

There are ongoing efforts to eliminate porcine reproductive and respiratory syndrome virus (PRRSv) from regions in the United States swine industry. However, an important challenge for the accomplishment of those efforts is the re-infection of pig units due to the area spread of PRRSv. The objective of this study was to evaluate the effect of PRRS modified-live virus vaccine (MLV) on viral shedding and on dynamics of PRRSv infection in pig populations raised under commercial conditions. The study composed of two rooms of 1000 pigs each. Ten percent of pigs of each room were inoculated with a field isolate of PRRSv. Rooms had separate air spaces and strict scientifically validated biosecurity protocols were adopted to avoid movement of pathogens between rooms. At 8 and 36 dpi (days post inoculation), all pigs of the challenge-vaccine group were inoculated with a MLV vaccine. Pigs of the challenge-control group were placebo-inoculated. Blood and oral fluid samples were collected from each room at 0, 8, 36, 70, 96 and 118 dpi for PRRSv RNA detection using PCR. PRRSv-antibodies were also screened from blood serum samples with a commercially available ELISA test. Additionally, tonsil scraping samples were collected from both groups at 70, 96 and 118 dpi. Moreover, air samples were collected 6 times per week from 0 to 118 dpi and were tested for PRRSv RNA using qPCR assay. There was no difference in the PRRSv infection dynamics measured as duration and magnitude of viremia and seroconversion. Also, there was no difference in the frequency of tonsil scraping samples PRRSv-positive by PCR. However, the challenge-vaccine group had significantly less PRRSv shed compared to the challenge-control group. The challenge-vaccine group had significant less PRRSv-positive oral fluids at 36 dpi. Moreover, the challenge-vaccine group had significant reduction in the cumulative PRRSv shed in the air.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22063389     DOI: 10.1016/j.vaccine.2011.10.075

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  28 in total

1.  Detection of Multiple Lineages of PRRSV in Breeding and Growing Swine Farms.

Authors:  Ting-Yu Cheng; Magnus R Campler; Declan C Schroeder; My Yang; Sunil K Mor; Juliana B Ferreira; Andréia G Arruda
Journal:  Front Vet Sci       Date:  2022-06-14

2.  Efficacy of Fostera PRRS modified live virus vaccine against a Canadian heterologous virulent field strain of porcine reproductive and respiratory syndrome virus.

Authors:  Christian Savard; Fernando Alvarez; Chantale Provost; Younes Chorfi; Sylvie D'Allaire; Marie-Odile Benoit-Biancamano; Carl A Gagnon
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

3.  Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus.

Authors:  Hae-Mi Nam; Kyung-Sil Chae; Young-Jo Song; Nak-Hyung Lee; Joong-Bok Lee; Seung-Yong Park; Chang-Seon Song; Kun-Ho Seo; Sang-Moo Kang; Min-Chul Kim; In-Soo Choi
Journal:  Arch Virol       Date:  2013-02-08       Impact factor: 2.574

4.  Genetic diversity of PRRS virus collected from air samples in four different regions of concentrated swine production during a high incidence season.

Authors:  Barbara Brito; Scott Dee; Spencer Wayne; Julio Alvarez; Andres Perez
Journal:  Viruses       Date:  2014-11-14       Impact factor: 5.048

5.  Comparison of different commercial ELISAs for detection of antibodies against porcine respiratory and reproductive syndrome virus in serum.

Authors:  Tatjana Sattler; Eveline Wodak; Sandra Revilla-Fernández; Friedrich Schmoll
Journal:  BMC Vet Res       Date:  2014-12-18       Impact factor: 2.741

6.  Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.

Authors:  Kang Ouyang; Jagadish Hiremath; Basavaraj Binjawadagi; Duan-Liang Shyu; Santosh Dhakal; Jesus Arcos; Rose Schleappi; Lynette Holman; Michael Roof; Jordi B Torrelles; Gourapura J Renukaradhya
Journal:  Vet Res       Date:  2016-03-17       Impact factor: 3.683

7.  Evaluation of Control Strategies for Porcine Reproductive and Respiratory Syndrome (PRRS) in Swine Breeding Herds Using a Discrete Event Agent-Based Model.

Authors:  Andréia Gonçalves Arruda; Robert Friendship; Jane Carpenter; Amy Greer; Zvonimir Poljak
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

Review 8.  Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccination.

Authors:  Emanuela Pileri; Enric Mateu
Journal:  Vet Res       Date:  2016-10-28       Impact factor: 3.683

9.  Immune Response of Multiparous Hyper-Immunized Sows against Peptides from Non-Structural and Structural Proteins of PRRSV.

Authors:  Edgar Rascón-Castelo; Alexel Burgara-Estrella; Mónica Reséndiz-Sandoval; Andrés Hernández-Lugo; Jesús Hernández
Journal:  Vaccines (Basel)       Date:  2015-11-27

10.  Effect of vaccination with a modified live porcine reproductive and respiratory syndrome virus vaccine on growth performance in fattening pigs under field conditions.

Authors:  Kwang-Soo Lyoo; Jong-Young Choi; Tae-Wook Hahn; Kun Taek Park; Hye Kwon Kim
Journal:  J Vet Med Sci       Date:  2016-06-06       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.